139 related articles for article (PubMed ID: 26022646)
1. The Co-Expression of Kallikrein 5 and Kallikrein 7 Associates with Poor Survival in Non-HPV Oral Squamous-Cell Carcinoma.
Leusink FK; van Diest PJ; Frank MH; Broekhuizen R; Braunius W; van Hooff SR; Willems SM; Koole R
Pathobiology; 2015; 82(2):58-67. PubMed ID: 26022646
[TBL] [Abstract][Full Text] [Related]
2. Cathepsin K associates with lymph node metastasis and poor prognosis in oral squamous cell carcinoma.
Leusink FK; Koudounarakis E; Frank MH; Koole R; van Diest PJ; Willems SM
BMC Cancer; 2018 Apr; 18(1):385. PubMed ID: 29618339
[TBL] [Abstract][Full Text] [Related]
3. Clinical relevance of copy number profiling in oral and oropharyngeal squamous cell carcinoma.
van Kempen PM; Noorlag R; Braunius WW; Moelans CB; Rifi W; Savola S; Koole R; Grolman W; van Es RJ; Willems SM
Cancer Med; 2015 Oct; 4(10):1525-35. PubMed ID: 26194878
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of kallikrein-related peptidase-4 in oral cancer.
Papagerakis P; Pannone G; Zheng LI; Athanassiou-Papaefthymiou M; Yamakoshi Y; McGuff HS; Shkeir O; Ghirtis K; Papagerakis S
Anticancer Res; 2015 Apr; 35(4):1861-6. PubMed ID: 25862839
[TBL] [Abstract][Full Text] [Related]
5. Parallel underexpression of kallikrein 5 and kallikrein 7 mRNA in breast malignancies.
Li X; Liu J; Wang Y; Zhang L; Ning L; Feng Y
Cancer Sci; 2009 Apr; 100(4):601-7. PubMed ID: 19453546
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Platelet-Derived Growth Factor and Its Receptor Are Correlated with Oral Tumorigenesis and Poor Prognosis in Oral Squamous Cell Carcinoma.
Lin LH; Lin JS; Yang CC; Cheng HW; Chang KW; Liu CJ
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235327
[TBL] [Abstract][Full Text] [Related]
7. Relative expression of KLK5 to LEKTI is associated with aggressiveness of oral squamous cell carcinoma.
Alves MG; Kodama MH; da Silva EZM; Gomes BBM; da Silva RAA; Vieira GV; Alves VM; da Fonseca CK; Santana AC; Cecílio NT; Costa MSA; Jamur MC; Oliver C; Cunha TM; Bugge TH; Braz-Silva PH; Colli LM; Sales KU
Transl Oncol; 2021 Jan; 14(1):100970. PubMed ID: 33260070
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of kallikrein-related peptidase 7 (KLK7) mRNA expression in advanced high-grade serous ovarian cancer.
Gong W; Liu Y; Diamandis EP; Kiechle M; Bronger H; Dorn J; Dreyer T; Magdolen V
J Ovarian Res; 2020 Oct; 13(1):125. PubMed ID: 33087135
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of quantitatively assessed KLK7 expression in ovarian cancer.
Kyriakopoulou LG; Yousef GM; Scorilas A; Katsaros D; Massobrio M; Fracchioli S; Diamandis EP
Clin Biochem; 2003 Mar; 36(2):135-43. PubMed ID: 12633763
[TBL] [Abstract][Full Text] [Related]
10. Nodal metastasis and survival in oral cancer: Association with protein expression of SLPI, not with LCN2, TACSTD2, or THBS2.
Noorlag R; van der Groep P; Leusink FK; van Hooff SR; Frank MH; Willems SM; van Es RJ
Head Neck; 2015 Aug; 37(8):1130-6. PubMed ID: 24764155
[TBL] [Abstract][Full Text] [Related]
11. Loss of NKX3-1 as a potential marker for an increased risk of occult lymph node metastasis and poor prognosis in oral squamous cell carcinoma.
Miyaguchi K; Uzawa N; Mogushi K; Takahashi K; Michikawa C; Nakata Y; Sumino J; Okada N; Mizushima H; Fukuoka Y; Tanaka H
Int J Oncol; 2012 Jun; 40(6):1907-14. PubMed ID: 22344708
[TBL] [Abstract][Full Text] [Related]
12. Differential splicing of KLK5 and KLK7 in epithelial ovarian cancer produces novel variants with potential as cancer biomarkers.
Dong Y; Kaushal A; Brattsand M; Nicklin J; Clements JA
Clin Cancer Res; 2003 May; 9(5):1710-20. PubMed ID: 12738725
[TBL] [Abstract][Full Text] [Related]
13. Clinical relevance of breast cancer-related genes as potential biomarkers for oral squamous cell carcinoma.
Parris TZ; Aziz L; Kovács A; Hajizadeh S; Nemes S; Semaan M; Chen CY; Karlsson P; Helou K
BMC Cancer; 2014 May; 14():324. PubMed ID: 24885002
[TBL] [Abstract][Full Text] [Related]
14. High expression of Naa10p associates with lymph node metastasis and predicts favorable prognosis of oral squamous cell carcinoma.
Zeng Y; Zheng J; Zhao J; Jia PR; Yang Y; Yang GJ; Ma JF; Gu YQ; Xu J
Tumour Biol; 2016 May; 37(5):6719-28. PubMed ID: 26662107
[TBL] [Abstract][Full Text] [Related]
15. Human kallikrein gene 5 (KLK5) expression by quantitative PCR: an independent indicator of poor prognosis in breast cancer.
Yousef GM; Scorilas A; Kyriakopoulou LG; Rendl L; Diamandis M; Ponzone R; Biglia N; Giai M; Roagna R; Sismondi P; Diamandis EP
Clin Chem; 2002 Aug; 48(8):1241-50. PubMed ID: 12142380
[TBL] [Abstract][Full Text] [Related]
16. Protease-activated Receptor-2 (PAR-2)-mediated Nf-κB Activation Suppresses Inflammation-associated Tumor Suppressor MicroRNAs in Oral Squamous Cell Carcinoma.
Johnson JJ; Miller DL; Jiang R; Liu Y; Shi Z; Tarwater L; Williams R; Balsara R; Sauter ER; Stack MS
J Biol Chem; 2016 Mar; 291(13):6936-45. PubMed ID: 26839311
[TBL] [Abstract][Full Text] [Related]
17. A 13-gene signature prognostic of HPV-negative OSCC: discovery and external validation.
Lohavanichbutr P; Méndez E; Holsinger FC; Rue TC; Zhang Y; Houck J; Upton MP; Futran N; Schwartz SM; Wang P; Chen C
Clin Cancer Res; 2013 Mar; 19(5):1197-203. PubMed ID: 23319825
[TBL] [Abstract][Full Text] [Related]
18. Caveolin 1 (Cav-1) and actin-related protein 2/3 complex, subunit 1B (ARPC1B) expressions as prognostic indicators for oral squamous cell carcinoma (OSCC).
Auzair LB; Vincent-Chong VK; Ghani WM; Kallarakkal TG; Ramanathan A; Lee CE; Rahman ZA; Ismail SM; Abraham MT; Zain RB
Eur Arch Otorhinolaryngol; 2016 Jul; 273(7):1885-93. PubMed ID: 26138391
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-1beta and Caspase-3 expression serve as independent prognostic markers for metastasis and survival in oral squamous cell carcinoma.
Singh P; Augustine D; Rao RS; Patil S; Sowmya SV; Haragannavar VC; Nambiar S
Cancer Biomark; 2019; 26(1):109-122. PubMed ID: 31356195
[TBL] [Abstract][Full Text] [Related]
20. The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage.
Pannone G; Santoro A; Feola A; Bufo P; Papagerakis P; Lo Muzio L; Staibano S; Ionna F; Longo F; Franco R; Aquino G; Contaldo M; De Maria S; Serpico R; De Rosa A; Rubini C; Papagerakis S; Giovane A; Tombolini V; Giordano A; Caraglia M; Di Domenico M
Curr Cancer Drug Targets; 2014; 14(2):115-27. PubMed ID: 24274398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]